Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.

Cationic drugs and COVID-19 / O.V. Brenna, S.S. Torretta, L. Pignataro, F. Di Berardino. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 2058-7384. - 34(2020), pp. 1-3.

Cationic drugs and COVID-19

Oreste Vittore Brenna;Sara Torretta;Lorenzo Pignataro;Federica Di Berardino
2020

Abstract

Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.
COVID-19; cationic drugs; emergency; infection; pandemic
Settore MED/31 - Otorinolaringoiatria
Article (author)
File in questo prodotto:
File Dimensione Formato  
2058738420966078(1).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 111.04 kB
Formato Adobe PDF
111.04 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/774524
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact